Article Details

GT Biopharma Transfers TriKE™ Manufacturing To Cytovance Biologics In Preparation For ...

Retrieved on: 2021-02-18 12:56:15

Tags for this article:

Click the tags to see associated articles and topics

GT Biopharma Transfers TriKE™ Manufacturing To Cytovance Biologics In Preparation For .... View article details on hiswai:

Excerpt

BEVERLY HILLS, Calif., Feb. 18, 2021 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage biopharmaceutical company focused on ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up